Related Experiment Video

Updated: Jun 10, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Diagnosis of invasive fungal infections in immunocompromised children

H J Dornbusch1, A Groll, T J Walsh

  • 1Division of Paediatric Haematology/Oncology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria. hansjuergen.dornbusch@medunigraz.at

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|August 4, 2010
PubMed

Insights

Prompt diagnosis and treatment are crucial for invasive fungal infections in children. Identifying the specific fungus and its drug resistance is vital for effective patient care, especially with rising resistance rates.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pediatric Medicine

Background:

  • Invasive fungal infections (IFIs) pose a significant threat to high-risk pediatric patients.
  • Increasing fungal pathogen diversity and antifungal resistance complicate treatment decisions.
  • Accurate and timely diagnosis is essential for effective management of IFIs.

Purpose of the Study:

  • To highlight the importance of early recognition and prompt treatment of IFIs in children.
  • To emphasize the need for species-level identification and drug resistance testing of fungal pathogens.
  • To discuss advancements in laboratory diagnosis for invasive mycoses.

Main Methods:

  • Review of current diagnostic standards for mycological diagnosis, including microscopy and culture.
  • Discussion of limitations associated with traditional diagnostic methods (e.g., specimen collection, culture duration, false negatives).
  • Exploration of advanced diagnostic techniques such as modern imaging and molecular detection (circulating fungal components and DNA).

Main Results:

  • Microscopy and culture remain the gold standard but have significant limitations.
  • Emerging diagnostic tools show promise in improving the detection of invasive mycoses.
  • Accurate identification and resistance profiling are critical for guiding antifungal therapy.

Conclusions:

  • Early and accurate diagnosis of invasive fungal infections in children is paramount for successful outcomes.
  • Advanced diagnostic methods are needed to overcome the limitations of traditional techniques.
  • Species-level identification and antifungal susceptibility testing are crucial for optimizing patient care and combating resistance.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...